NCT06938165View on ClinicalTrials.gov

The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

GVHD

Interventions

OTHER

Fecal Microbiota Transplant (FMT)

FMT in patients with refractory GVHD

Trial Locations (1)

520000

Nanfang hospital, Guangzhou

All Listed Sponsors

lead

Nanfang Hospital, Southern Medical University

OTHER

NCT06938165 - The Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host Disease | Biotech Hunter | Biotech Hunter